Literature DB >> 16061605

Excess soluble fms-like tyrosine kinase 1 and low platelet counts in premature neonates of preeclamptic mothers.

Po-Nien Tsao1, Shu-Chen Wei, Yi-Ning Su, Hung-Chieh Chou, Chien-Yi Chen, Wu-Shiun Hsieh.   

Abstract

OBJECTIVE: To investigate the relationship of neonatal platelet count and preeclampsia to levels of soluble fms-like tyrosine kinase 1 (sFlt-1), placental growth factor (PlGF), and vascular endothelial growth factor (VEGF) in the cord blood of preterm infants.
METHODS: Sixty-nine preterm infants with a gestational age between 26 and 37 weeks at birth were enrolled. sFlt-1, PlGF, and VEGF levels in the cord blood of preterm neonates, with or without maternal preeclampsia, were measured using a standardized sandwich enzyme-linked immunosorbent assay method.
RESULTS: Infants with maternal preeclampsia had higher cord blood sFlt-1 but lower PlGF and VEGF levels. There was a significantly positive relationship between neonatal platelet count and birth weight and a significantly negative relationship between neonatal platelet count and cord blood sFlt-1 levels. Multiple regression analysis revealed that only birth weight and cord blood sFlt-1 levels were independently related to neonatal platelet count, whereas maternal preeclampsia, gestational age (GA), and small for GA (SGA) were not related. Neonates with thrombocytopenia had higher cord blood sFlt-1 levels but lower birth weight. A significant correlation was also found between birth weight and cord blood sFlt-1 levels. Multiple regression with birth weight as the dependent variable found that only GA and cord blood sFlt-1 levels were independently related. Furthermore, infants with high cord blood sFlt-1 were more likely to have lower platelet count and maternal preeclampsia, be SGA, and have a trend toward lower birth weight.
CONCLUSION: Excess sFlt-1 may play an important role in the development of maternal preeclampsia- induced neonatal thrombocytopenia, and SGA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16061605     DOI: 10.1542/peds.2004-2240

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  14 in total

1.  Increased expression of sFlt-1 in in vivo and in vitro models of human placental hypoxia is mediated by HIF-1.

Authors:  Ori Nevo; Nima Soleymanlou; Yuan Wu; Jing Xu; John Kingdom; Ariel Many; Stacy Zamudio; Isabella Caniggia
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2006-04-20       Impact factor: 3.619

Review 2.  Pathogenesis and treatment of bronchopulmonary dysplasia.

Authors:  Jason Gien; John P Kinsella
Journal:  Curr Opin Pediatr       Date:  2011-06       Impact factor: 2.856

3.  Cord blood biomarkers of vascular endothelial growth (VEGF and sFlt-1) and postnatal growth: a preterm birth cohort study.

Authors:  Stephannie Baehl Voller; Susanne Chock; Linda M Ernst; Emily Su; Xin Liu; Kathryn N Farrow; Karen K Mestan
Journal:  Early Hum Dev       Date:  2014-01-27       Impact factor: 2.079

Review 4.  Bronchopulmonary dysplasia: Pathogenesis and treatment.

Authors:  Asfia Banu Pasha; Xiao-Qing Chen; Guo-Ping Zhou
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

5.  Inflammation-related proteins in the blood of extremely low gestational age newborns. The contribution of inflammation to the appearance of developmental regulation.

Authors:  Alan Leviton; Raina Fichorova; Yoshika Yamamoto; Elizabeth N Allred; Olaf Dammann; Jonathan Hecht; Karl Kuban; Thomas McElrath; T Michael O'Shea; Nigel Paneth
Journal:  Cytokine       Date:  2010-10-08       Impact factor: 3.861

6.  Placental vascular lesions differ between male and female fetuses in early-onset preeclampsia.

Authors:  Hadas Miremberg; Hadas Ganer Herman; Mor Bustan; Eran Weiner; Letizia Schreiber; Jacob Bar; Michal Kovo
Journal:  Arch Gynecol Obstet       Date:  2021-11-16       Impact factor: 2.493

7.  The maternal plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated in SGA and the magnitude of the increase relates to Doppler abnormalities in the maternal and fetal circulation.

Authors:  Tinnakorn Chaiworapongsa; Jimmy Espinoza; Francesca Gotsch; Yeon Mee Kim; Gi Jin Kim; Luis F Goncalves; Samuel Edwin; Juan Pedro Kusanovic; Offer Erez; Nandor Gabor Than; Sonia S Hassan; Roberto Romero
Journal:  J Matern Fetal Neonatal Med       Date:  2008-01

Review 8.  Pre-eclampsia and offspring cardiovascular health: mechanistic insights from experimental studies.

Authors:  Esther F Davis; Laura Newton; Adam J Lewandowski; Merzaka Lazdam; Brenda A Kelly; Theodosios Kyriakou; Paul Leeson
Journal:  Clin Sci (Lond)       Date:  2012-07       Impact factor: 6.124

9.  Preeclampsia and the risk of bronchopulmonary dysplasia in VLBW infants: a population based study.

Authors:  Ting-An Yen; Hwai-I Yang; Wu-Shiun Hsieh; Hung-Chieh Chou; Chien-Yi Chen; Kuo-Inn Tsou; Po-Nien Tsao
Journal:  PLoS One       Date:  2013-09-20       Impact factor: 3.240

Review 10.  Impaired adenosine-mediated angiogenesis in preeclampsia: potential implications for fetal programming.

Authors:  Carlos Escudero; James M Roberts; Leslie Myatt; Igor Feoktistov
Journal:  Front Pharmacol       Date:  2014-06-05       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.